- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05343286
Biological & Fonctional Signatures for Muscle Failures, Aged People & Personalized Physical Activity (BioFaSt)
Biological & Fonctional Signatures for Muscle Failures, Aged People & Personalized Physical Activity : BioFaSt MAPPA
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Main objective: To determine the effects of personalized physical activity management on the biological signatures of muscle failure.
Secondary objectives:
- Propose a support system through adapted and individualized physical activity, based on physical, biological and psycho-social indicators
- Identify the biological signatures (metabolomics, epigenetic) of muscle failure in the elderly.
Phenotype responders and non-responders in training
900 seniors (300 per group) APAP group: adapted and personalized physical activity APA group: adapted physical activity Control group: no physical activity
Total duration of the study 5 years, duration of participation for a patient 3 months; inclusion period: 57 months
Improvement of muscle failure in its broad definition (Strength, power, speed and lean mass)
) General data: description of characteristics with frequencies and percentage for categorical variables and with mean and standard deviation for quantitative variables.
ii) Analysis of the primary endpoint: Machine Learning (or supervised classification) and signaling pathway prediction approaches for statistical analysis and data interpretation.
iii) Analysis of secondary judgment criteria: approaches in Machine Learning (or supervised classification) and signaling pathway prediction for statistical analysis and interpretation of data with comparison of quantitative variables by Pearson correlation and categorical variables by t or chi 2 test depending on the case.
Adapt and individualize physical activity support for healthy or frail elderly people
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Fréderic CHORIN, PhD
- Phone Number: 0492034924
- Email: chorin.f@chu-nice.fr
Study Contact Backup
- Name: Olivier GUERIN, PU-PH
- Phone Number: 0492034194
- Email: guerin.o@chu-nice.fr
Study Locations
-
-
-
Nice, France, 06000
- Recruiting
- CHU de Nice
-
Contact:
- Olivier Guérin, PU-PH
- Phone Number: +33 (0)4 92 03 41 94
- Email: guerin.o@chu-nice.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age greater than or equal to 60 years
- Affiliated patient or beneficiary of a social security scheme
- Patient having signed a prior informed consent.
Exclusion criteria
- Neurocognitive disorder preventing the expression of informed consent
- Patients protected by law under guardianship or curatorship, or who cannot participate in a clinical study under Article L. 1121-16 of the French Public Health Code
- Presence of a physical or cognitive pathology preventing the performance of the adapted physical activity protocol over 3 months.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: APAP group: adapted and personalized physical activity
12 weeks of adapted and personalized physical activity
|
blood sample before and after 12 weeks of physical activity
physical assessement before and after 12 weeks of physical activity
Psychometric questionnaires
|
|
Active Comparator: APA group: adapted physical activity
12 weeks of generic physical activity
|
blood sample before and after 12 weeks of physical activity
physical assessement before and after 12 weeks of physical activity
Psychometric questionnaires
|
|
Sham Comparator: Control group: no physical activity
no physical activity
|
blood sample before and after 12 weeks of physical activity
physical assessement before and after 12 weeks of physical activity
Psychometric questionnaires
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
muscle power
Time Frame: before and after 12 week of physical activity program
|
muscle power (Watt/Kg) assessed with the isokinetic ergometer.
|
before and after 12 week of physical activity program
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Different metabolomic signature (The amino acid composition) between the groups (APA, APAP, no physical activity)
Time Frame: at day 0
|
Change in the amino acid composition (metabolomic signature) at Day 0 between the groups
|
at day 0
|
|
Change in the amino acid composition (metabolomic signature) after 3 month of physical activity
Time Frame: between Day 0 and Month 3
|
Change in the amino acid composition (metabolomic signature) after 3 month of physical activity for the APA and APAP groups compared to the no physical activity group
|
between Day 0 and Month 3
|
|
ICOPE Monitor Assessment
Time Frame: before and after 12 week of physical activity program
|
Score of frailty.
(Implementation of the Integrated Care of Older People, ICOPmonitor, 8 item, higher score means worse outcome)
|
before and after 12 week of physical activity program
|
|
Sit-to-stand Test
Time Frame: before and after 12 week of physical activity program
|
number of movement
|
before and after 12 week of physical activity program
|
|
Quantified Gait Analysis (QAM)
Time Frame: before and after 12 week of physical activity program
|
Gait velocity in m.s-1
|
before and after 12 week of physical activity program
|
|
Bone densitometer measurement of body composition
Time Frame: before and after 12 week of physical activity program
|
% of lean mass
|
before and after 12 week of physical activity program
|
|
Cognitive tests
Time Frame: before and after 12 week of physical activity program
|
Score Mini-Mental State Examination (MMSE, 0-30, higher score mean worse outcome)
|
before and after 12 week of physical activity program
|
|
The long questionnaire of personality traits
Time Frame: before and after 12 week of physical activity program
|
Score of Big Five Inventory, 0-44, higher score means worse outcome
|
before and after 12 week of physical activity program
|
|
Perceived health (Score of the scale)
Time Frame: before and after 12 week of physical activity program
|
Score of the scale, 0-6, higher score means better outcome
|
before and after 12 week of physical activity program
|
|
Subjective age
Time Frame: before and after 12 week of physical activity program
|
Subjective age in years
|
before and after 12 week of physical activity program
|
|
Age group identification (Years)
Time Frame: before and after 12 week of physical activity program
|
Age group identification in years
|
before and after 12 week of physical activity program
|
|
Attitudes towards aging
Time Frame: before and after 12 week of physical activity program
|
Score on the French version of the Attitudes Toward Own Aging scales, 0-7, higher score means better outcome
|
before and after 12 week of physical activity program
|
|
Physical self-perception
Time Frame: before and after 12 week of physical activity program
|
Score on the French version of the Physical Self-Perception Profile, 0-6, higher score means better outcome
|
before and after 12 week of physical activity program
|
|
Motivation scale for physical activity for health purposes
Time Frame: before and after 12 week of physical activity program
|
Score on the Motivation Scale for Physical Activity in a Health Context,0-30, higher score means better outcome
|
before and after 12 week of physical activity program
|
|
Aging Stereotypes and Exercise Scale
Time Frame: before and after 12 week of physical activity program
|
Score on the French Aging Stereotypes and Exercise Scale (ASES), 0-12, higher score means better outcome
|
before and after 12 week of physical activity program
|
|
Improvement of muscle force
Time Frame: before and after 12 week of physical activity program
|
Improvement of muscle force (N/Kg) assessed with the isokinetic ergometer.
|
before and after 12 week of physical activity program
|
Collaborators and Investigators
Investigators
- Principal Investigator: Olivier GUERIN, PU-PH, geriatric Department
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 21-PP-24
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Elderly
-
University of Rome Foro ItalicoEnrolling by invitationAging | Elderly | Frail Elderly | Aging Frailty | Sarcopenia in ElderlyItaly
-
DSM Nutritional Products, Inc.CompletedFrail Elderly | Pre-frail ElderlyNetherlands
-
Maimonides Medical CenterCompletedElderly | Frail Elderly | Hospitalization | Geriatrics
-
University of ThessalyCompletedFunctionality, Falls, Elderly, Fall Prevention, Exercise Elderly, Assessment, Rehabilitation, Community-DwellingGreece
-
Indian Council of Medical ResearchSt Johns Medical College Hospital, Bangalore, IndiaRecruiting
-
Burdur Mehmet Akif Ersoy UniversityPamukkale UniversityCompleted
-
Hospital Israelita Albert EinsteinConselho Nacional de Desenvolvimento Científico e Tecnológico; Paulo de Tarso...Completed
-
Istanbul Medipol University HospitalCompleted
-
Seoul National University HospitalCompleted
-
Purdue UniversityCompleted
Clinical Trials on blood sample
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
Medical University of WarsawCompletedArthroplasty | Platelet Aggregation | Methylmethacrylate EmbolismPoland
-
The First Affiliated Hospital of Soochow UniversityRecruitingGraft Vs Host DiseaseChina
-
Centre Hospitalier Universitaire DijonRecruiting
-
University of FloridaNational Heart, Lung, and Blood Institute (NHLBI)WithdrawnHeart FailureUnited States
-
University Hospital, ToulouseInstitut National de la Santé Et de la Recherche Médicale, France; ANRS, Emerging...Completed
-
GlaxoSmithKlineCompletedInfections, StreptococcalBelgium
-
Institut PasteurCentre Terrritorial Hospitalier Gaston BourretNot yet recruiting
-
First Affiliated Hospital of Zhejiang UniversityRecruitingComplication | Hematologic Malignancy | Hematopoietic Stem Cell Transplantation | Chronic Graft-versus-host-diseaseChina
-
University Hospital, BordeauxMinistry for Health and Solidarity, FranceRecruitingImmune Thrombocytopenia | Autoimmune Hemolytic Anemia | Autoimmune NeutropeniaFrance